Clinical Trial Update: 5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating azacitidine given before allogeneic stem cell transplantation in high-risk myelodysplastic syndrome has completed, and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-08-03